United States · FDA National Drug Code directory
Rivastigmine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-1197_7f578c0e-20d3-4f6d-bb1d-5e99b770ebf0
- Product NDC
- 70710-1197
- Form
- PATCH, EXTENDED RELEASE
- Composition / generic term
- Rivastigmine
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190306
- Source listing expiry
- 20261231
Source-listed ingredients
- RIVASTIGMINE — 9.5 mg/24h
These values do not establish equivalence or a dose recommendation.
Packages
- 30 POUCH in 1 CARTON (70710-1197-7) / 24 h in 1 POUCH (70710-1197-1) · 70710-1197-7
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →